RE: GSK/HLN split26 Jul 2022 00:18
cas
''if as Pfizer have said they intend to sell down their stake in Haleon that will hold the SP down for the foreseeable future''
That is complete nonsense - the share price ultimately will be determined by the market based on current and prospective future profitability.
The government/taxpayer owned 43% of Lloyds bank that the market knew had to be sold. That did not stop the shares from rising as the shares were sold off, resulting in an average sale price for the taxpayer in the 70's.
''The ULVR bid (which may have involved the absorption of some debt ''
The offer was worth £50 Billion which included taking on all of the £10 Billion debt , therefore equal to a current market cap offer of £40 Billion.
''it may be that the new HLN board are minded to accept an offer of £4 ''
that would be for them to decide whether to recommend such an offer to shareholders, but at the start of the year was deemed to undervalue the business.
As I said it was a consolidation resulting in a 20% reduction in shares not a reduction of a quarter as you stated, which would of course by a 25% reduction.
''thus creating , for the naive holder,the impression that the value of their stock on GSK remains the same.''
i am sure the vast majority of investors on here are aware that about 19% of the value that they invested in old GSK became their investment in Haleon.
''I sold out of both companies a few months ago ''
That is all I need to know - which may explain any posting you may make on this and the Haleon board